BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MBS314 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of MBS314\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07911748-3432@assetmemo.bio
DTSTAMP:20261121T004552Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:MBS314: Phase 1/2 readout est. (NCT07911748)
DESCRIPTION:MBS314\, phase 1/2\, Multiple Myeloma.\nStudy: A Study of MBS31
 4 for Injection in Participants With Relapsed/Refractory Multiple Myeloma.
 \nEstimated primary completion: December 2027. This is a ClinicalTrials.go
 v estimate\, not a confirmed readout date\, and it can move.\nDrug page: h
 ttps://assetmemo.bio/drug/mbs314#upcoming-events\nRegistry record: https:/
 /clinicaltrials.gov/study/NCT07911748
URL:https://assetmemo.bio/drug/mbs314#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
